Pharm 47 Asthma Flashcards
Anticholinergics (2)
Ipratropium, Tiotropium
MOA:
Antagonist at muscurinic receptor on airway smooth muscle and glands= decreased bronchoconstriction
Ipratropium, Tiotropium (Anticholinergics)
Tx:
Asthma, COPD
Ipratropium, Tiotropium
B-Adrenergic Agonists (12)
Epinephrin, Isoproterenol, Isoetharine, Metaproterenol, Terbutaline, Albuterol (Salbutamol), Levalbuteraol, Pirbuterol, Bitolterol, Formoterol, Salmeterol, Arformoterol
MOA:
Agonist to B-adrenergic receptors; acts on G protein to relax smooth muscle
B-Adrenergics
Tx:
Asthma, Cardiac arrest, shock, heart block, Stokes-Adams syndrome
Isoproterenol
Tx:
Anaphylaxis, asthma, open-angle glaucoma, cardiac arrest
Epinephrine
Adverse affects:
cardiac arrhythmias, hypertensive crisis, pulmonary edema
Epinephrine
MOA:
phosphodiesterase inhibitor preventin degradation of cAMP; also acts on adenosine receptor antagonists= smooth muscle relaxation
Methylxanthines
Methylxanthines (2)
Theophylline, Aminophylline
Adverse effect:
vent. arrhythmia, sz,
Theophylline, Aminophylline
Consideration:
plasma levels must be monitord to prevent toxic levels
Theophylline, Aminophylline
MOA:
Inhibit calcium transport into smooth muscle cells= relaxation
Magnesium sulfate
Tx: atrial paroxysmal tachycardia eclampsia cerebral edema barium poisoning sz hypomagnesia
magnesium sulfate
Consideration:
Tocolytic agent causing uterine relaxation thus preventing preterm labor
magnesium sulfate
MOA:
inhibit COX-2 action and prostglandin by inducing lipocortins
Inhaled corticosteroids
Inhaled Corticosteroids (7)
Beclomethasone, Triamcinolone, Fluticasone, Budesonide, Flunisolide, Mometasone, Ciclesonide
MOA:
Inhibit chloride transport, which affects calcium gating to prevent ganule release= decreased mast cell response
Cromolyns
Cromolyns (2)
Cromolyn, Nedocromil
Tx:
keratoconjunctivitis, mast-cell disorder, vernal conjunctivitis
Cromolyn, Nedocromil
Considerations:
Good for exercise-induced asthma
primarily prophylactic therapy
Most affective in young adults & children
Cromolyn, Nedocromil
MOA:
Inhibit 5-lipoxygenase= decreased leukotreine synthesis
Leukotriene pathway modifying agents
MOA:
cysteinyl leukotreine receptor antagonist
Montelukast, Zafirlukast
Leukotriene pathway modifying agents (3)
Zileuton, Montelukast, Zafirlukast
MOA:
Humanized mouse, high affinity IgE-receptor, Prevents IgE from binding to receptor on mast cells; and decreases circulating IgE= decreased allergic response to asthma
Anti-immunoglobulin E antibodies
Considerations:
High cost- limited to severe asthma
Administered every 2-4 weeks SQ
Omalizumab
Anti-immunoglobulin E antibodies (1)
Omalizumab